Safety of rituximab in children with auto-immune diseases

Safety of rituximab in children with auto-immune diseases

Bibliographic Details
Main Authors:	Bader-Meunier B, Quartier P, Wouters C
Format:	Article
Language:	English
Published:	BMC 2008-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

Rituximab for auto-immune alveolar proteinosis, a real life cohort study
by: Berenice Soyez, et al.
Published: (2018-04-01)

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
by: Aniek Lamberts, et al.
Published: (2018-02-01)

Rituximab for rheumatic diseases in children: Results of a retrospective study of the safety of therapy
by: M. I. Kaleda, et al.
Published: (2021-05-01)

Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
by: Celine Kaegi, et al.
Published: (2019-09-01)

Safety of rituximab in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011-06-01)

Rituximab for children with immune thrombocytopenia: a systematic review.
by: Yi Liang, et al.
Published: (2012-01-01)

Response to rituximab in children and adults with immune thrombocytopenia (ITP)
by: Emily M. Harris, et al.
Published: (2021-08-01)

Inflammatory arthritis associated with inflammatory bowel disease in children
by: Desgranges M, et al.
Published: (2008-09-01)

Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis
by: Xiangjun Dou, et al.
Published: (2020-12-01)

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
by: Caterina Vacchi, et al.
Published: (2021-01-01)

Efficacy and safety of rituximab biosimilar in refractory lupus
by: Nantakarn Pongtarakulpanit, et al.
Published: (2020-12-01)

Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01)

Efficacy and Safety of Rituximab in Children with Refractory Nephrotic Syndrome; A Multicenter Clinical Trial
by: Yo Han Ahn, et al.
Published: (2014-06-01)

6-Month Effectiveness Safety and Tolerability of Ocrelizumab and Comparative Safety with Rituximab
by: Moss, Brandon Price
Published: (2020)

Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children
by: Mahmoud Nermine H, et al.
Published: (2009-07-01)

Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
by: Masoud Etemadifar, et al.
Published: (2017-01-01)

The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis
by: Şenol Kobak, et al.
Published: (2013-01-01)

Safety of switching between rituximab biosimilars in onco-hematology
by: Silvana A. M. Urru, et al.
Published: (2021-03-01)

THE EFFICACY AND SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS: NEW EVIDENCE
by: D. A. Kusevich, et al.
Published: (2017-09-01)

Rituximab in Minimal Change Disease
by: Nima Madanchi, et al.
Published: (2017-03-01)

Rituximab in Autoimmune CNS Disease
by: J Gordon Millichap, et al.
Published: (2014-08-01)

Rituximab in the treatment of skin diseases
by: Murlidhar Rajagopalan, et al.
Published: (2017-01-01)

Rituximab in kidney disease and transplant
by: Kajal Chauhan, et al.
Published: (2019-06-01)

Infantile Onset Panniculitis with Uveitis and Systemic Granulomatosis: immunohistochemical findings
by: Wouters CH, et al.
Published: (2008-09-01)

Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases.
by: Anza B Memon, et al.
Published: (2018-01-01)

Successful treatment with rituximab of refractory immune thrombocytopenic purpura
by: Daniela Tirotta, et al.
Published: (2009-12-01)

Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis
by: Jia Wang, et al.
Published: (2018-01-01)

Rituximab Iodination Procedure for Radioiodinated Rituximab (131I-Rituximab) Preparation
by: Martalena Ramli, et al.
Published: (2019-06-01)

EFFICACY AND SAFETY OF RITUXIMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A RETROSPECTIVE STUDY OF THE CASE SERIES
by: Ekaterina I. Alexeeva, et al.
Published: (2016-11-01)

Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
by: Biswanath Basu, et al.
Published: (2020-11-01)

Coexistent sickle-cell anemia and autoimmune disease in eight children: pitfalls and challenges
by: Valerie Li-Thiao-Te, et al.
Published: (2018-01-01)

Safety of rituximab on testicles, a double-blindedcontrolled trial in mice
by: Sultan Mogren Al-Mogairen
Published: (2020-01-01)

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
by: Nicolas Collongues, et al.
Published: (2016-05-01)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
by: Joanna Tieu, et al.
Published: (2021-05-01)

Rituximab for refractory granulomatous eye disease
by: Lower EE, et al.
Published: (2012-10-01)

Current perspective on rituximab in rheumatic diseases
by: Schioppo T, et al.
Published: (2017-10-01)

TREATMENT OF COLD AGGLUTININ DISEASE WITH RITUXIMAB
by: Marjana Glaser
Published: (2008-04-01)

2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)
by: Ruperto N, et al.
Published: (2008-09-01)

Rituximab Leads to Long Remissions in Patients with Chronic Immune Thrombocytopenia
by: Khalid Al-Habsi, et al.
Published: (2015-03-01)

Rituximab and Immune Molecule Modulation in Burkitt’s Lymphoma Cell Lines
by: Rebecca Quilty, et al.
Published: (2019-05-01)

Cannot write session to /tmp/vufind_sessions/sess_6r2hq4oepaleg6n2mo14mvr4a0